Ancrod: understanding the agent.
Illig
K A
KA
Department of Surgery, University of Rochester Medical Center, NY 14642, USA.
Ouriel
K
K
D000721:Ancrod / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D000925:Anticoagulants / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D001777:Blood Coagulation / Q000187:drug effects*; D001026:Coronary Artery Bypass; D005340:Fibrinogen / Q000032:analysis; D005342:Fibrinolysis / Q000187:drug effects; D006493:Heparin / Q000009:adverse effects; D006801:Humans; D011655:Pulmonary Embolism / Q000188:drug therapy; D013921:Thrombocytopenia / Q000139:chemically induced; D013927:Thrombosis / Q000188:drug therapy; D014656:Vascular Surgical Procedures
D000925:Anticoagulants; D005340:Fibrinogen; D006493:Heparin; D000721:Ancrod